Source: Annual Congress 2001 - Physiological and disease-related changes in lung cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. L. Woodman, F. E. Woisin, M. W. Jensen, S. D. Greenaway, E. Staite, B. J. O'Connor, V. Kanabar (London, United Kingdom). Clinical severity of asthma. Can it be measured in sputum?. Eur Respir J 2001; 16: Suppl. 31, 567

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Examination of patients whose eosinophilic ratio in sputum was more than 3% with wheezing or cough symptoms Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015 Chronic cough and sputum production: a clinical COPD phenotype? Source: Eur Respir J 2012; 40: 4-6 Year: 2012 Clinical characteristics and health status of spontaneous sputum producers in COPD Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults Source: Eur Respir J 2007; 30: Suppl. 51, 587s Year: 2007 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 Sputum interleukin-25 correlates with asthma severity - a preliminary study Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003